Advertisement

Fall 43: Therapie – 48 Jahre, ♀, Hashimoto-Thyreoiditis

  • Daniel Pfaff
Chapter

Zusammenfassung

Bei einer 48-jährigen Patientin mit einem BMI von 29 wird jetzt ein Prädiabetes festgestellt, und es stellt sich die Frage, ob sie weiter Selen einnehmen soll, das ihr wegen der Hashimoto-Thyreoiditis der naturheilkundlich orientierte Kollege verschrieben hatte. Sollte die Seleneinnahme weitergeführt oder beendet werden?

Literatur

  1. Aaseth J, Frey H, Glattre E, Norheim G, Ringstad J, Thomassen Y (1990) Selenium concentrations in the human thyroid gland. Biol Trace Elem Res 24(2):147–152CrossRefGoogle Scholar
  2. Anastasilakis AD, Toulis KA, Nisianakis P, Goulis DG, Kampas L, Valeri RM, Oikonomou D, Tzellos TG, Delaroudis S (2012) Selenomethionine treatment in patients with autoimmune thyroiditis: a prospective, quasi-randomised trial. Int J Clin Pract 66(4):378–383.  https://doi.org/10.1111/j.1742-1241.2011.02879.xCrossRefPubMedGoogle Scholar
  3. Bartalena L, Baldeschi L, Boboridis K, Eckstein A, Kahaly GJ, Marcocci C, Perros P, Salvi M, Wiersinga WM (2016) The 2016 European thyroid association/European group on graves’ orbitopathy guidelines for the management of graves’ orbitopathy. Eur Thyroid j 5(1):9–26.  https://doi.org/10.1159/000443828CrossRefPubMedPubMedCentralGoogle Scholar
  4. Bektas Uysal H, Ayhan M (2016) Autoimmunity affects health-related quality of life in patients with Hashimoto’s thyroiditis. Kaohsiung J Med Sci 32(8):427–433.  https://doi.org/10.1016/j.kjms.2016.06.006CrossRefPubMedGoogle Scholar
  5. Duntas LH, Mantzou E, Koutras DA (2003) Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. Eur J Endocrinol 148(4):389–393CrossRefGoogle Scholar
  6. Esposito D, Rotondi M, Accardo G, Vallone G, Conzo G, Docimo G, Selvaggi F, Cappelli C, Chiovato L, Giugliano D, Pasquali D (2017) Influence of short-term selenium supplementation on the natural course of Hashimoto’s thyroiditis: clinical results of a blinded placebo-controlled randomized prospective trial. J Endocrinol Invest 40(1):83–89.  https://doi.org/10.1007/s40618-016-0535-4CrossRefPubMedGoogle Scholar
  7. Galan-Chilet I, Grau-Perez M, De Marco G, Guallar E, Martin-Escudero JC, Dominguez-Lucas A, Gonzalez-Manzano I, Lopez-Izquierdo R, Briongos-Figuero LS, Redon J, Chaves FJ, Tellez-Plaza M (2017) A gene-environment interaction analysis of plasma selenium with prevalent and incident diabetes: the Hortega study. Redox Biol 12:798–805.  https://doi.org/10.1016/j.redox.2017.04.022CrossRefPubMedPubMedCentralGoogle Scholar
  8. Gartner R, Gasnier BC, Dietrich JW, Krebs B, Angstwurm MW (2002) Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J Clin Endocrinol Metab 87(4):1687–1691.  https://doi.org/10.1210/jcem.87.4.8421CrossRefPubMedGoogle Scholar
  9. Karanikas G, Schuetz M, Kontur S, Duan H, Kommata S, Schoen R, Antoni A, Kletter K, Dudczak R, Willheim M (2008) No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid: Official Journal Of The American Thyroid Association 18(1):7–12.  https://doi.org/10.1089/thy.2007.0127CrossRefGoogle Scholar
  10. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD 3rd, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL Jr, Baker LH, Coltman CA Jr (2009) Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301(1):39–51.  https://doi.org/10.1001/jama.2008.864CrossRefPubMedGoogle Scholar
  11. Lu CW, Chang HH, Yang KC, Kuo CS, Lee LT, Huang KC (2016) High serum selenium levels are associated with increased risk for diabetes mellitus independent of central obesity and insulin resistance. BMJ open diab res & care 4(1):e000253.  https://doi.org/10.1136/bmjdrc-2016-000253CrossRefGoogle Scholar
  12. Nacamulli D, Mian C, Petricca D, Lazzarotto F, Barollo S, Pozza D, Masiero S, Faggian D, Plebani M, Girelli ME, Mantero F, Betterle C (2010) Influence of physiological dietary selenium supplementation on the natural course of autoimmune thyroiditis. Clin Endocrinol 73(4):535–539.  https://doi.org/10.1111/j.1365-2265.2009.03758.xCrossRefGoogle Scholar
  13. Negro R, Attanasio R, Grimaldi F, Marcocci C, Guglielmi R, Papini E (2016) A 2016 Italian survey about the clinical use of selenium in thyroid disease. Eur Thyroid J 5(3):164–170.  https://doi.org/10.1159/000447667CrossRefPubMedPubMedCentralGoogle Scholar
  14. Stranges S, Marshall JR, Natarajan R, Donahue RP, Trevisan M, Combs GF, Cappuccio FP, Ceriello A, Reid ME (2007) Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med 147(4):217–223CrossRefGoogle Scholar
  15. Vinceti M, Dennert G, Crespi CM, Zwahlen M, Brinkman M, Zeegers MP, Horneber M, D’Amico R, Del Giovane C (2014) Selenium for preventing cancer. The Cochrane database of systematic reviews (3):Cd005195.  https://doi.org/10.1002/14651858.cd005195.pub3
  16. Winther KH, Cramon P, Watt T, Bjorner JB, Ekholm O, Feldt-Rasmussen U, Groenvold M, Rasmussen AK, Hegedus L, Bonnema SJ (2016) Disease-specific as well as generic quality of life is widely impacted in autoimmune hypothyroidism and improves during the first six months of levothyroxine therapy. PloS one 11(6):e0156925.  https://doi.org/10.1371/journal.pone.0156925CrossRefPubMedPubMedCentralGoogle Scholar
  17. Winther KH, Watt T, Bjorner JB, Cramon P, Feldt-Rasmussen U, Gluud C, Gram J, Groenvold M, Hegedus L, Knudsen N, Rasmussen AK, Bonnema SJ (2014) The chronic autoimmune thyroiditis quality of life selenium trial (CATALYST): study protocol for a randomized controlled trial. Trials 15:115.  https://doi.org/10.1186/1745-6215-15-115CrossRefPubMedPubMedCentralGoogle Scholar
  18. Wu Q, Rayman MP, Lv H, Schomburg L, Cui B, Gao C, Chen P, Zhuang G, Zhang Z, Peng X, Li H, Zhao Y, He X, Zeng G, Qin F, Hou P, Shi B (2015) low population selenium status is associated with increased prevalence of thyroid disease. J Clin Endocrinol Metab 100(11):4037–4047.  https://doi.org/10.1210/jc.2015-2222CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2018

Authors and Affiliations

  1. 1.Abteilung Innere Medizin IMedizinische UniversitätsklinikHeidelbergDeutschland

Personalised recommendations